Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
RenovoRx, Inc. - Common Stock
(NQ:
RNXT
)
1.210
+0.090 (+8.04%)
Delayed Quote
Updated: 3:31 PM EDT, Oct 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about RenovoRx, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
RenovoRx Eyes 2027 TIGeR-PaC Readout as RenovoCath Expands to 21 Centers
↗
August 16, 2026
RenovoRx (NASDAQ:RNXT) executives and physician speakers discussed the treatment landscape for locally advanced pancreatic cancer, the company’s Trans-Arterial Micro-Perfusion, or TAMP, platform, and...
Via
MarketBeat
RenovoRx Q2 Earnings Call Highlights
↗
August 12, 2026
RenovoRx (NASDAQ:RNXT) reported record second-quarter revenue as it expanded its commercial cancer-center network and advanced its clinical program for locally advanced pancreatic cancer. For the...
Via
MarketBeat
Topics
Earnings
RenovoRx (RNXT) Q2 2026 Earnings Call Transcript
↗
August 12, 2026
Record $909K revenue driven by cancer center expansion and Phase III trial completion.
Via
The Motley Fool
Topics
Earnings
Earnings Scheduled For November 13, 2025
↗
November 13, 2025
Via
Benzinga
Earnings Scheduled For August 14, 2025
↗
August 14, 2025
Via
Benzinga
Earnings Preview For RenovoRx
↗
May 14, 2025
Via
Benzinga
RNXT Stock Earnings: RenovoRx Meets EPS for Q2 2024
↗
August 13, 2024
RNXT stock results show that RenovoRx met analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
RenovoRx (RNXT) Q1 2026 Earnings Transcript
↗
May 19, 2026
RenovoRx (RNXT) Q1 2026 Earnings Transcript
Via
The Motley Fool
Top movers in Monday's pre-market session
↗
January 12, 2026
Via
Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
↗
November 14, 2025
Via
Benzinga
RENOVORX INC (NASDAQ:RNXT) Reports Significant Q3 2025 Revenue Miss and 5% Stock Drop
↗
November 13, 2025
RenovoRx Q3 2025 earnings show a 35% revenue miss, causing a stock drop. The clinical-stage biopharma provided a 2026 growth outlook to offset cash burn.
Via
Chartmill
RenovoRx (RNXT) Q3 2025 Earnings Call Transcript
↗
November 13, 2025
RenovoRx (RNXT) Q3 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Economy
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
November 10, 2025
Via
Benzinga
Top 4 Biotech Stocks Set For A Breakout: Momentum Scores Surge
↗
September 08, 2025
Several biotech stocks are showing renewed strength over the past week, with their Momentum scores soaring in Benzinga's Edge Stock Rankings.
Via
Benzinga
Curious about the stocks that are showing activity after the closing bell on Wednesday?
↗
September 03, 2025
As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via
Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
↗
August 15, 2025
Via
Benzinga
Gapping stocks in Friday's session
↗
August 15, 2025
The session on Friday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Via
Chartmill
What's going on in today's pre-market session
↗
August 15, 2025
Let's have a look at what is happening on the US markets before the opening bell on Friday. Below you can find the top gainers and losers in today's pre-market session.
Via
Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
August 15, 2025
Via
Benzinga
RenovoRx Revenue Jumps 28 Percent in Q2
↗
August 14, 2025
Via
The Motley Fool
Topics
Intellectual Property
RenovoRx Inc. (NASDAQ:RNXT) Q2 2025 Earnings: Revenue Surpasses Estimates, Shares Climb on Positive Results
↗
August 14, 2025
RenovoRx (NASDAQ:RNXT) Q2 2025 revenue beats estimates at $422K, shares rise 4.8%. RenovoCath adoption grows, Phase III trial progresses. Strong cash position supports operations.
Via
Chartmill
12 Health Care Stocks Moving In Friday's After-Market Session
↗
June 27, 2025
Via
Benzinga
Earnings Scheduled For May 15, 2025
↗
May 15, 2025
Via
Benzinga
These stocks are moving in today's pre-market session
↗
April 14, 2025
The US market is yet to commence its session on Monday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via
Chartmill
12 Health Care Stocks Moving In Monday's After-Market Session
↗
April 07, 2025
Via
Benzinga
What's going on in today's pre-market session
↗
February 07, 2025
Discover the top movers in Friday's pre-market session and stay informed about market dynamics.
Via
Chartmill
These stocks are moving in today's after hours session
↗
February 06, 2025
Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
December 02, 2024
Via
Benzinga
Exact Sciences To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Thursday
↗
September 12, 2024
Via
Benzinga
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
June 14, 2024
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
